Cara Therapeutics Inc CARA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
15.93UNCH (UNCH)
Volume
8,951
Close
15.93quote price arrow up+0.08 (+0.50%)
Volume
511,472
52 week range
11.22 - 29.65
Loading...
  • Open15.82
  • Day High16.13
  • Day Low15.79
  • Prev Close15.85
  • 52 Week High29.65
  • 52 Week High Date04/09/21
  • 52 Week Low11.22
  • 52 Week Low Date08/04/21

Key Stats

  • Market Cap797.93M
  • Shares Out50.09M
  • 10 Day Average Volume0.73M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change5.29

KEY STATS

  • Open15.82
  • Day High16.13
  • Day Low15.79
  • Prev Close15.85
  • 52 Week High29.65
  • 52 Week High Date04/09/21
  • 52 Week Low11.22
  • 52 Week Low Date08/04/21
  • Market Cap797.93M
  • Shares Out50.09M
  • 10 Day Average Volume0.73M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change5.29

RATIOS/PROFITABILITY

  • EPS (TTM)0.11
  • P/E (TTM)149.30
  • Fwd P/E (NTM)-8.81
  • EBITDA (MRQ)7.071M
  • ROE (MRQ)4.85%
  • Revenue (MRQ)123.29M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)6.78%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cara Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The Company operates through the activities related to the discovery and development of therapeutics to treat serious medical conditions, including pain and...
Derek Chalmers Ph.D.
President
Thomas Reilly
Chief Financial Officer
Address
4 Stamford Plz
Stamford, CT
06902-3834
United States

Top Peers

SYMBOLLASTCHG%CHG
DTIL
Precision BioSciences Inc
12.63-0.83-6.17%
ANAB
AnaptysBio Inc
27.34-0.75-2.67%
CPRX
Catalyst Pharmaceuticals Inc
5.08+0.03+0.59%
RIGL
Rigel Pharmaceuticals Inc
3.74-0.15-3.86%
ATNX
Athenex Inc
3.22-0.20-5.85%